| Identification | Back Directory | [Name]
Teroxalene hydrochloride | [CAS]
3845-22-5 | [Synonyms]
A-16612
PR-3847
NSC 138704
Teroxalene HCl
Teroxalene hydrochloride
1-(3-CHLORO-P-TOLYL)-4-(6-(4-TERT-PENTYLPHENOXY)-HEXYL)-PIPERAZINE HCL
1-[6-(4-tert-amylphenoxy)hexyl]-4-(3-chloro-4-methyl-phenyl)piperazine hydrochloride
1-(3-chloro-4-methylphenyl)-4-[6-[4-(2-methylbutan-2-yl)phenoxy]hexyl]piperazine hydrochloride
1-(3-chloro-4-methyl-phenyl)-4-[6-[4-(2-methylbutan-2-yl)phenoxy]hexyl]piperazine hydrochloride | [Molecular Formula]
C28H42Cl2N2O | [MDL Number]
MFCD00035328 | [MOL File]
3845-22-5.mol | [Molecular Weight]
493.552 |
| Hazard Information | Back Directory | [Uses]
Teroxalene hydrochloride is an orally active schistosomiasis agent[1]. | [Brand name]
Teroxalene is INN. | [References]
[1] A Abdallah, et al. Evaluation of a new oral compound, Abbott-16612 in the treatment of bilharziasis. J Egypt Med Assoc. 1968;51(6):580-6. PMID:5725862 |
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|